HyperfineHYPR
HYPR
About: Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.
Employees: 111
0
Funds holding %
of 7,296 funds
0
Analysts bullish %
of 3 analysts
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
0% more funds holding
Funds holding: 38 [Q4 2024] → 38 (+0) [Q1 2025]
3.0% less ownership
Funds ownership: 18.7% [Q4 2024] → 15.7% (-3.0%) [Q1 2025]
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
26% less capital invested
Capital invested by funds: $9.53M [Q4 2024] → $7.07M (-$2.46M) [Q1 2025]
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$0.68
6%
downside
Avg. target
$1.06
47%
upside
High target
$1.50
108%
upside
3 analyst ratings
2 positive
67%
1 neutral
33%
0 negative
0%
B. Riley Securities Yuan Zhi | 39%upside $1 | Buy Maintained | 15 May 2025 |
Wells Fargo Larry Biegelsen | 6%downside $0.68 | Equal-Weight Maintained | 14 May 2025 |
Lake Street Frank Takkinen | 108%upside $1.50 | Buy Initiated | 24 Mar 2025 |
Financial journalist opinion
Based on 4 articles about HYPR published over the past 30 days
Neutral
Business Wire
5 days ago
Hyperfine Announces Key Executive Appointments to Strengthen its Leadership Position in AI-Powered Portable MRI
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine appoints Rob Fasciano, PhD, and Rafael O'Halloran, PhD, to help advance AI-powered MRI technology and scale next-gen imaging solutions.
Positive
Zacks Investment Research
1 week ago
Hyperfine Stock Rises After FDA Clears Next-Gen Swoop MRI System
HYPR secures FDA clearance for its next-gen Swoop system, advancing bedside MRI tech and reinforcing its mission to revolutionize accessible neuroimaging.
Neutral
Business Wire
2 weeks ago
Hyperfine Announces FDA Clearance of a New Next-Generation Swoop® System Powered by Optive AI™ Software, Delivering a Transformative Leap in Image Quality
GUILFORD, Conn.--(BUSINESS WIRE)--FDA clears next-gen Swoop® MRI system with Optive AI™ software, bringing a transformative leap in image quality with enhanced usability and comfort.
Neutral
Business Wire
2 weeks ago
Hyperfine Announces FDA Clearance of Optive AI™ Software, Introducing the Most Substantial Image Quality Improvement Ever for the Swoop® System
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the world's first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced FDA clearance of its next-generation software. This tenth-generation release delivers a substantial leap in image quality for ultra-low-field MR imaging. Optive AI™ software enhances each stage of the imaging process—from noise cancellation.
Neutral
Business Wire
1 month ago
Hyperfine, Inc. to Participate in Upcoming Jefferies Global Healthcare Conference
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced plans to present at the upcoming Jefferies Global Healthcare Conference on Thursday, June 5th at 4:20pm Eastern Time (ET). Management will also be hosting in-person meetings on Wednesday, June 4th. To schedule a one-on-one meetin.
Neutral
Seeking Alpha
1 month ago
Hyperfine, Inc. (HYPR) Q1 2025 Earnings Call Transcript
Hyperfine, Inc. (NASDAQ:HYPR ) Q1 2025 Earnings Conference Call May 13, 2025 4:30 PM ET Company Participants Webb Campbell - Investor Relations Maria Sainz - President and Chief Executive Officer Brett Hale - Chief Administrative Officer and Chief Financial Officer Conference Call Participants Frank Takkinen - Lake Street Yuan Zhi - B. Riley Securities Operator Thank you for standing by.
Neutral
Zacks Investment Research
1 month ago
Hyperfine, Inc. (HYPR) Reports Q1 Loss, Lags Revenue Estimates
Hyperfine, Inc. (HYPR) came out with a quarterly loss of $0.12 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.14 per share a year ago.
Neutral
GlobeNewsWire
1 month ago
Hyperfine, Inc. Reports First Quarter 2025 Financial Results
GUILFORD, Conn., May 13, 2025 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced first quarter 2025 financial results and provided a business update.
Neutral
Business Wire
1 month ago
Hyperfine, Inc. to Announce First Quarter 2025 Financial Results on May 13, 2025
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced that it will report financial results for the first quarter 2025 on Tuesday, May 13, 2025. Management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. A live audio webcast and an archive of the r.
Neutral
Business Wire
2 months ago
Hyperfine Enrolls Initial Patients in NEURO PMR Study to Evaluate Use of AI-Powered Portable MRI in Neurology Offices
GUILFORD, Conn.--(BUSINESS WIRE)--Study examines clinical utility and patient experience of AI-powered portable MRI in neurology offices.
Charts implemented using Lightweight Charts™